<DOC>
	<DOC>NCT00574548</DOC>
	<brief_summary>The objective of this study is to compare the safety, tolerability and immunologic response to a dose of 23vPS or 13vPnC given one year after either 13vPnC or 23vPS in subjects that have never received a previous dose of 23vPS.</brief_summary>
	<brief_title>Study Evaluating the Safety, Tolerability and Immunogenicity of 13vPnC as a 2-Dose Regimen or With 23vPS</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Male or Female, aged 60 to 64 years. Healthy. Previous vaccination with any licensed or experimental pneumococcal vaccine. History of severe adverse reaction associated with a vaccine. Immunodeficiency.</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Vaccines, Pneumococcal Conjugate Vaccine</keyword>
</DOC>